Skip to main content
. 2020 Sep 23;12:8935–8941. doi: 10.2147/CMAR.S261887

Table 3.

The Cytogenetically Risk Profile of All 59 Patients

Cytogenetic Abnormality n (%)
1q21 8 (13.6)
17p- 5 (8.5)
t (14,16) 3 (5.1)
t (11,14) 3 (5.1)
t (4,14) 2 (3.4)
Other mutations 7 (11.9)
More than two mutations 12 (20.3)
Negative 19 (32.2)